TG and neoplasm: This applies above all to patients in whom induction of hypothyroidism is associated with unacceptably high risks, or in whom adequate endogenous TSH stimulation cannot be achieved, for example due to a hypothalamo-pituitary disorder, or due to thyroid hormone-producing tumor tissue [31,32,66].